The disruption in GH/IGF-1 axis activity may be responsible, at least in part, for metabolic alterations, which are common in children with OSA and increase the risk of cardiovascular events, as well as mortality (39). This evidence concerns the gene IGF1 and obstructive sleep apnea syndrome.